Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

'Molecular Therapeutics' Prove Their Mettle In Clinical Trials

June 12, 2002

CeNeS Divests Test Division As Part Of Restructuring

June 12, 2002

ML Labs Divesting Unit Through Flotation On AIM

June 12, 2002

E&Y Report: Firms Finding Ways To Thrive In Downturn

June 12, 2002

CeNeS Divests Test Division As Part Of Restructuring

June 12, 2002

Stem Cell Research Moves Forward Around The World

June 12, 2002

Pfizer Rep: Improved Drugs' Benefits Get Poor Accounting

June 11, 2002

Data Glut Prompting More Deals Between Biotech, IT

June 11, 2002

Pfizer Rep: Improved Drugs' Benefits Get Poor Accounting

June 11, 2002

Data Glut Prompting More Deals Between Biotech, IT

June 11, 2002

View All Articles by Nuala Moran

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...